Hyperspectral reconstruction
Reconstruction of rich hyperspectral data from standard dermoscopy images, revealing tissue characteristics invisible to the naked eye.
Revolutionizing skin cancer detection
Super intelligence
Super intelligence
for dermatology
We use AI to improve existing diagnostic tools, such as dermoscopes, supporting more accurate detection of skin cancer and other dermatological conditions and helping clinicians make more reliable decisions in everyday practice.
- Works with existing dermatoscopes
- Supports, never replaces, clinical judgment
Specally Insight
Standard dermoscopic image, captured with an existing dermatoscope.
No new hardware
Works with existing dermatoscopes, no additional devices required.
AI reconstruction
Hyperspectral, biologically relevant data derived from a single image.
Physician support
Complements, rather than replaces, the physician's clinical judgment.
Technology
Cutting-edge technology
Our proprietary AI algorithms combine dermatological expertise with deep learning to give physicians deeper insight into every lesion.
AI-powered analysis
Advanced neural networks trained on thousands of dermatological images for precise pattern recognition and skin cancer detection.
Medical expertise
We work with healthcare professionals from leading medical and research institutions to ensure our technology is rigorously validated and seamlessly integrates into the clinical workflow.
How it works
From a standard image to deeper insight
Specally Insight uses artificial intelligence to reconstruct hyperspectral information from standard dermoscopic images, enriching the ordinary image with biologically relevant data about the lesion.
-
1
Image capture
The physician captures a standard image of the lesion using an existing dermatoscope.
-
2
AI reconstruction
The algorithm reconstructs hyperspectral, biologically relevant tissue data from the image.
-
3
Clinical report
The physician receives a clear visualization that supports the diagnostic decision.
Solutions
Comprehensive solutions
From early screening to precise diagnosis and surgical excision, we support the entire clinical workflow.
-
Stage 01
Early screening
Screening and triage system designed to rapidly differentiate between malignant and benign lesions in the early stages.
-
Stage 02
Precise diagnosis
Support in identifying various skin conditions, including skin cancer and benign lesions.
-
Stage 03
Surgical guidance
Real-time assistance for defining precise lesion margins during surgery.
Designed for clinicians
Specally Insight is designed primarily for dermatologists and other healthcare professionals who manage skin lesions. It can be used wherever dermoscopic examinations, diagnosis, and treatment planning are performed.
-
Dermatologists
A more detailed view of the lesion during routine examinations and differential diagnostics.
-
Oncologists and surgeons
Additional information for more precise surgical planning and defining excision margins.
-
Clinics and healthcare centers
An upgrade to the existing diagnostic workflow, with no need for new imaging hardware.
Added value
More insight from the imaging you already use
The key added value of Specally Insight lies in extracting substantially more clinically useful information from existing dermoscopic imaging, without tying the software to a new imaging device.
Specally Insight does not replace the physician. It provides additional information about the lesion and helps with diagnosis, early detection, and surgical planning.
| Aspect | With Specally Insight | Standard dermoscopy |
|---|---|---|
| Visible lesion characteristics | Yes | Yes |
| Biologically relevant data (perfusion, O2, melanin) | Yes | No |
| New hardware required | Not required | — |
| Support for defining lesion borders | Yes | Limited |
| Role in the diagnostic process | Physician support | Baseline exam |
Our vision
We are developing super intelligence for dermatology
AI that reveals tissue characteristics invisible to the naked eye, turning every dermoscopic image into deeper, biologically relevant insight for the clinicians who rely on it.
About
About Specally
Specally was founded by a team of two medical physicists and an experimental oncologist with 15+ years of combined experience in the field. We are a research-led, innovation-driven and clinically focused medtech startup at the forefront of revolutionizing skin cancer detection through next-generation imaging technology and artificial intelligence.
Our mission is to make advanced dermatological diagnostics accessible to healthcare providers worldwide, enabling early skin cancer detection and improved patient outcomes.
- Research-led
- Innovation-driven
- Clinically focused
- 15+
- Years of combined experience in medical physics and oncology
- 3
- Co-founders covering diverse fields, from AI and engineering to clinical research
- 9
- Team members across R&D, clinical studies and business development
Our team
-
Co-founder
Tadej Tomanič, PhD
Algorithm and software development
-
Co-founder
Črt Keber
Hardware development and system administration
-
Co-founder
Tim Božič, PhD
Clinical studies and medical regulation
-
Sara Cajnar
Market analysis and marketing
-
Sabina Sladič Oblak
Business development and customer outreach
Students
-
Žiga Arnič
Computer vision
-
Milka Gruber
Computer vision
-
Urban Vesel
LLMs and RAG
-
Maks Koncilja
Agentic AI systems
Contact
Get in touch
Ready to transform your dermatology practice? Contact us to learn more about our solutions and for collaboration.
Emailinfo@specally.ai
Together we can advance skin cancer diagnostics.
This operation benefits from support from the European Union under the InvestEU Fund
